Source-grounded facts extracted from Alignment Healthcare, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Alignment Healthcare, Inc. shareholders approved Say-on-Pay Vote on the executive compensation of the Company's named executive officers at the 2026-06-04 meeting.
“Proposal 3: Say-on-Pay Vote. On an advisory basis, the executive compensation of the Company’s named executive officers was approved based on the following votes: For Against Abstain Broker Non-Vote 169,068,300 8,701,941 542,191 15,800,560”
Alignment Healthcare, Inc. shareholders approved Ratification of the Appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 at the 2026-06-04 meeting.
“Proposal 2: Ratification of the Appointment of Deloitte & Touche LLP. The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified based upon the following votes: For Against Abstain 194,030,577 13,893 68,522”
Alignment Healthcare, Inc. shareholders approved Election of Class II Directors at the 2026-06-04 meeting.
“Proposal 1: Election of Class II Directors. The three Class II directors were elected at the Annual Meeting based upon the following votes: Class I Director Name For Withhold Broker Non-Vote Jody Bilney 135,714,231 42,598,200 15,800,560 David Hodgson 108,386,550 69,925,881 15,800,560 Jacqueline Kosecoff 135,613,817 42,698,614 15,800,560”
Alignment Healthcare, Inc.: Amended Article III, Section 6 of the bylaws to add the position of Vice Chair of the Board and define duties including presiding over board meetings in the Chairman's absence (effective 2026-05-06).
“On May 6, 2026, the Board of Directors of Alignment Healthcare, Inc. (the "Company") unanimously approved an amendment (the "Amendment") to the Company's Amended and Restated Bylaws (the "Bylaws"), effective immediately. The Amendment amends and restates Article III, Section 6 to provide (i) for the position of Vice Chair of the Board and (ii) that a Vice Chair will have such duties as may from time to time be requested by the Board of Directors and that in the absence of the Chairman, a Vice Chair will preside over meetings of the Board.”
Alignment Healthcare, Inc. reported first quarter ended March 31, 2026 results: revenue $1,235.2 million, net income $11.4 million. Guidance raised.
“PRESS RELEASE EdgarFiling EXHIBIT 99.1 Alignment Healthcare Delivers Strong First Quarter 2026 Results, Demonstrating Disciplined Growth and Margin Expansion Delivers $1.24 billion in total revenue, representing 33.3% growth year-over-year Grows Medicare Advantage membership 30.9% year-over-year to approximately 284,800 members Raises the midpoint of all”
Alignment Healthcare, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC and the selling stockholder listed on Schedule II thereto (effective 2026-03-02).
“On March 2, 2026, Alignment Healthcare, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC (the “Underwriter”) and the selling stockholder listed on Schedule II thereto (the “Selling Stockholder”) with respect to an underwritten offering by the Selling Stockholder of 13,167,733 shares (the “Shares”) of the Company’s common stock”
Hakan Kardes resigned as Chief Experience Officer at Alignment Healthcare, Inc..
“On April 9, 2025, Hakan Kardes, Chief Experience Officer of Alignment Healthcare, Inc. (the “Company”), notified the Company of his intention to resign his employment with the Company to pursue other professional opportunities.”
Dawn Maroney changed role as President at Alignment Healthcare, Inc..
“On January 13, 2025, Alignment Healthcare, Inc. (the “Company”) announced that Dawn Maroney has been promoted to President of the Company, effective immediately”
Thomas Carella resigned as Director at Alignment Healthcare, Inc..
“On August 13, 2024 and August 14, 2024, respectively, Jeffrey Margolis and Thomas Carella each notified the Board of Directors (the "Board") of Alignment Healthcare, Inc. (the "Company") of their decision to resign as a member of the Board, effective immediately.”
Jeffrey Margolis resigned as Director at Alignment Healthcare, Inc..
“On August 13, 2024 and August 14, 2024, respectively, Jeffrey Margolis and Thomas Carella each notified the Board of Directors (the "Board") of Alignment Healthcare, Inc. (the "Company") of their decision to resign as a member of the Board, effective immediately.”
Alignment Healthcare, Inc. reported first quarter ended March 31, 2024 results: revenue $628.6 million, net income $(46.6) million. Guidance raised.
“in such filing. --- EX-99.1 (PRESS RELEASE) --- EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Alignment Healthcare Reports First Quarter 2024 Results Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% y ear-over-year respectively Medicare Advantage membership grows 50.5% year-over-year to”
Alignment Healthcare, Inc. reported full year ended December 31, 2023 results: revenue $1,823.6 million, net income $(148.2) million. Guidance initiated.
“Total revenue was $1,823.6 million, up 27.2% year over year Health plan premium revenue of $1,800.9 million represented 25.8% growth year over year Adjusted gross profit was $208.8 million and loss from operations was ($127.8) million Adjusted gross profit excludes depreciation and amortization of $21.7 million and selling, general, and administrative expenses of $307.4 million (which includes $59.3 million of equity-based compensation). Adjusted gross profit also excludes an additional $7.5 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 88.5% Adjusted EBITDA was ($35.3) million and net loss was ($148.2) million”
Alignment Healthcare, Inc. reported fourth quarter ended December 31, 2023 results: revenue $465.4 million, net income $(47.2) million. Guidance initiated.
“Health plan membership at the end of the quarter was approximately 119,200, up 21.1% year over year Total revenue was $465.4 million, up 28.6% year over year Health plan premium revenue of $459.0 million represented 27.5% growth year over year Adjusted gross profit was $49.2 million and loss from operations was ($41.9) million Adjusted gross profit excludes depreciation and amortization of $5.9 million and selling, general, and administrative expenses of $83.7 million (which includes $14.1 million of equity-based compensation). Adjusted gross profit also excludes an additional $1.5 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 89.4% Adjusted EBITDA was ($19.7) million and net loss was ($47.2) million”
Joseph Konowiecki changed role as Chairman of the Board at Alignment Healthcare, Inc..
“Pursuant to the Amendment, Mr. Konowiecki will no longer serve in an executive role leading strategic network and business development (the "Executive Role"), effective as of December 31, 2023”
Alignment Healthcare, Inc. reported third quarter ended September 30, 2023 results: revenue $456.7 million. Guidance raised.
“2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Alignment Healthcare Reports Third Quarter 2023 Results; Exceeds Guidance Across All Key Financial Metrics Reports $456.7 million in total revenue, up 26.7% year-over-year Medicare Advantage enrollment increases to approximately 115,600 members, up 18% year-over-year Outperforms on four key performance”
Hyong (Ken) Kim, M.D. was appointed as Chief Medical Officer at Alignment Healthcare, Inc..
“On September 6, 2023, Alignment Healthcare, Inc. (the “Company”) announced that Hyong (Ken) Kim, M.D., will serve as its Chief Medical Officer, effective as of September 25, 2023.”
Dr. Dinesh Kumar departed as Chief Medical and Operating Officer at Alignment Healthcare, Inc..
“On August 9, 2023, Alignment Healthcare, Inc. (the "Company") and Dr. Dinesh Kumar reached a mutual agreement of employment separation, pursuant to which Dr. Kumar will no longer serve as the Company’s Chief Medical and Operating Officer, effective as of October 1, 2023 (the “Effective Date”).”
Alignment Healthcare, Inc. reported its second quarter ended June 30, 2023 results: revenue $462.4 million, net income $(28.5) million. Guidance reaffirmed.
“--- EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Alignment Healthcare Reports Second Quarter 2023 Results; Beats Outlook Across All Four Critical KPIs Reports $462.4 million in total revenue, up 26.2% year-over-year Medicare Advantage enrollment increases to approximately 112,200 members, up 17% year-over-year ORANGE, Calif., Aug. 03, 2023 (GLOBE”
Richard Cross departed as Senior Vice President, General Counsel and Corporate Secretary at Alignment Healthcare, Inc..
“On July 11, 2023, Mr. Richard Cross, Senior Vice President, General Counsel and Corporate Secretary of Alignment Healthcare, Inc. (the “Company”), informed the Company that he plans to retire from his position effective as of September 1, 2023 (the “Effective Date”).”
Alignment Healthcare, Inc. shareholders approved Say-on-Pay Vote - Advisory vote on executive compensation at the 2023-06-06 meeting.
“Proposal 3: Say-on-Pay Vote . On an advisory basis, the executive compensation of the Company’s named executive officers was approved, based on the following votes: For Against Abstain Broker Non-Vote 110,852,417 54,729,829 277,422 12,513,924”
Alignment Healthcare, Inc. shareholders approved Ratification of the Appointment of Deloitte & Touche LLP at the 2023-06-06 meeting.
“Proposal 2 : Ratification of the Appointment of Deloitte & Touche LLP . The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2023 was ratified based upon the following votes: For Against Abstain 177,600,419 760,995 12,178”
Alignment Healthcare, Inc. shareholders approved Election of Class II Directors at the 2023-06-06 meeting.
“Proposal 1: Election of Class II Directors . The four Class II directors were elected at the Annual Meeting based upon the following votes: Class II Director Nominee For Withhold Broker Non-Vote Jody Bilney 148,754,241 17,105,427 12,513,924 David Hodgson 147,141,990 18,717,678 12,513,924 Jacqueline Kosecoff 129,137,939 36,721,729 12,513,924 Jeffrey Margolis 156,919,563 8,940,105 12,513,924”
Alignment Healthcare, Inc. reported the three months ending March 31, 2023 and the fiscal year ending December 31, 2023 results: revenue $429 $434 $1,705 $1,730. Guidance initiated.
“Revenue $429 $434 $1,705 $1,730 Adjusted Gross Profit 1 $38 $41 $205 $217 Adjusted EBITDA 2 ($17) ($14) ($34) ($20)”
Alignment Healthcare, Inc. reported the fiscal year ended December 31, 2022 results: revenue $1,434.2 million, net income ($149.6) million.
“Total revenue was $1,434.2 million, up 22.8% year over year Health plan premium revenue of $1,372.3 million represented 22.4% growth year over year Adjusted gross profit was $193.6 million and loss from operations was ($128.6) million Adjusted gross profit excludes depreciation and amortization of $17.5 million and selling, general, and administrative expenses of $295.6 million (which includes $72.6 million of equity-based compensation). Adjusted gross profit also excludes an additional $9.1 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 86.5% Adjusted EBITDA was ($26.7) million and net loss was ($149.6) million”
Alignment Healthcare, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $361.8 million, net income ($57.0) million.
“Total revenue was $361.8 million, up 21.3% year over year Health plan premium revenue of $344.9 million represented 21.5% growth year over year Adjusted gross profit was $38.3 million and loss from operations was ($52.1) million Adjusted gross profit excludes depreciation and amortization of $4.8 million and selling, general, and administrative expenses of $83.2 million (which includes $20.5 million of equity-based compensation). Adjusted gross profit also excludes an additional $2.4 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 89.4% Adjusted EBITDA was ($23.7) million and net loss was ($57.0) million”
Alignment Healthcare, Inc. reported third quarter ended September 30, 2022 results: revenue $360.3 million, net income ($40.2) million. Guidance raised.
“EdgarFiling EXHIBIT 99.1 Alignment Healthcare Reports Third Quarter Results; Continues to Beat Guidance Across All Key Financial Metrics; Raises Full-Year 2022 Outlook Reports $360.3 million in total revenue, up 22.8% year-over-year Exceeds high end of guidance on four key performance indicators: membership, revenue, adjusted gross profit and adjusted EBITDA Earns”
Rajesh Shrestha was terminated as President, New Markets and Chief Business Officer at Alignment Healthcare, Inc..
“mutually agreed to terminate his employment as President, New Markets and Chief Business Officer of the Company, effective as of April 1, 2022.”
Yon Yoon Jorden was elected as director at Alignment Healthcare, Inc..
“On December 23, 2021, the Board of Directors of Alignment Healthcare, Inc. (the “Company”) elected Jody Bilney and Yon Yoon Jorden as directors, effective as of January 1, 2022.”
Jody Bilney was elected as director at Alignment Healthcare, Inc..
“On December 23, 2021, the Board of Directors of Alignment Healthcare, Inc. (the “Company”) elected Jody Bilney and Yon Yoon Jorden as directors, effective as of January 1, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.